ZYBERNO
Stock Report
Updated Aug 30, 2026

CELCUITY INC. (CELC)

Healthcare • NASDAQ

$88.44

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
6.0/100
POOR BUSINESS
CELCUITY INC. (CELC) scores 6/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-350.8%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-210.9%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

CELCUITY INC. (CELC) stock report — Zyberno Score 6/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, CELC generated -$172.67M in Owner Earnings. Capital was deployed as follows: $438.00K invested in capital expenditures. Reinvestment rate: -0.1%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:88.44
Market Cap:$4.85B

Valuation Multiples (1)

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$4.12B

Price Action & Momentum (2)

B. Profitability Assessment

Return Metrics (5)

ROA:-41.5%
Reinvestment Rate:-0.1%
Fundamental Growth Rate (g):0.1%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$4.86
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-21.8%
Latest Earnings Filed:2026-08-13
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:8.93x
Quick Ratio:8.93x
Cash Ratio:8.68x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-7.73x
Times Interest Earned:-7.73

Capital Structure (4)

Working Capital:688,968,000.00
Cash And Cash Equivalents:754,000,000.00
Long Term Debt:$893.00K
Net Debt:-$732.53M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$208.68M

Bottom Line Performance (3)

-$226.48M
Income Before Tax:-$226.48M
Ebitda Ttm:-208,498,000.00

Operating Expenses (5)

Operating Expenses:208,675,000.00
R And D Expense:136,686,000.00
Sga Expense:71,989,000.00
Income Tax Expense:$0.00
Interest Expense:22,269,000.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$828.22M
Current Assets:$775.84M
Ppe Net:611,000.00
Goodwill:0.00
Intangible Assets:$50.00M

Liability Structure (4)

Total Liabilities:841,001,000.00
Current Liabilities:86,873,000.00
Long Term Debt:$893.00K
Short Term Debt:$20.58M

Equity & Capital (3)

Equity:-$12.78M
Retained Earnings:-$580.60M
Common Stock:95,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:8,093,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:6,904,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$172.49M-$172.93M

Investment Activities (2)

Investing Cash Flow:$34.52M
Capital Expenditures Ttm:438,000.00

Financing Activities (3)

Financing Cash Flow:$34.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:177,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-4.30
-$4.30
Earnings Per Share Ttm:-$4.13

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$2.80

Book Value & Capital (2)

Book Value Per Share:-$0.23
Cash Per Share:13.75

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:60.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$172.67M

Damodaran Growth Analysis (2)

Reinvestment Rate:-0.1%
Fundamental Growth Rate (g):0.1%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):6.7%
C. Company Profile & Context

Corporate Information (6)

Symbol:CELC
Company Name:CELCUITY INC.
Sector:Healthcare
Industry:Services-Medical Laboratories
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:high
Volume Category:N/A

Share Structure (3)

Shares Outstanding:54.82M
Shares Outstanding Basic:54.82M
Shares Outstanding Diluted:54.82M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-30 09:01:11 UTC
Data Timestamp:2026-08-30T09:01:11.910251
Scroll to Top